. . . . "4939"^^ . "2"^^ . . . "Na bun\u011B\u010Dn\u00E9 \u00FArovni lze prok\u00E1zat schopnost oxerutinu chr\u00E1nit c\u00E9vn\u00ED st\u011Bnu p\u0159ed oxida\u010Dn\u00EDm \u00FAtokem aktivovan\u00FDch krevn\u00EDch bun\u011Bk a jeho afinitu k\u00A0endotelu kapil\u00E1r a venul.\nVe studi\u00EDch u zdrav\u00FDch jedinc\u016F nebo u pacient\u016F s\u00A0chronickou \u017Eiln\u00ED insuficienc\u00ED lze dolo\u017Eit tyto farmakodynamick\u00E9 \u00FA\u010Dinky oxerutinu:\nsn\u00ED\u017Een\u00ED permeability kapil\u00E1r\nobnoven\u00ED veno-arteriol\u00E1rn\u00EDho reflexu\nprodlou\u017Een\u00ED \u010Dasu ke\u00A0znovunapln\u011Bn\u00ED \u017Eil \u201Evenous refilling time\u201C\nzv\u00FD\u0161en\u00ED transkut\u00E1nn\u00ED tenze kysl\u00EDku\nV\u0161echny tyto \u00FA\u010Dinky jsou kompatibiln\u00ED s\u00A0prim\u00E1rn\u00EDm \u00FA\u010Dinkem oxerutinu lokalizovan\u00FDm na endotelu kapil\u00E1r s\u00A0n\u00E1slednou redukc\u00ED ed\u00E9mu."@cs . . . . "5525"^^ . . .